2009
DOI: 10.1016/j.jconrel.2009.05.029
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
13
0
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 29 publications
4
13
0
1
Order By: Relevance
“…Over the past few decades, poly(lactide-co-glycolic acid) (PLGA) microparticles have been used as carriers for delivery of drugs of varying chemical makeup and to achieve controlled release property after parenteral [1], oral [2] and pulmonary administration [3,4].show Edwards and others have reported that prolonged release inhalable formulations of various drugs can be developed by engineering the size and density of PLGA based particles [5,6]. PLGA particles with reduced density of b 0.4 g/ml and geometric diameter > 5 μm can address many limitations associated with conventional nonporous inhalable particles of unit density (1 g/ml).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Over the past few decades, poly(lactide-co-glycolic acid) (PLGA) microparticles have been used as carriers for delivery of drugs of varying chemical makeup and to achieve controlled release property after parenteral [1], oral [2] and pulmonary administration [3,4].show Edwards and others have reported that prolonged release inhalable formulations of various drugs can be developed by engineering the size and density of PLGA based particles [5,6]. PLGA particles with reduced density of b 0.4 g/ml and geometric diameter > 5 μm can address many limitations associated with conventional nonporous inhalable particles of unit density (1 g/ml).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, LMWHs are administered by subcutaneous injection for the treatment of deep vein thrombosis and pulmonary embolism [16]. To develop noninvasive drug delivery systems for LMWHs, we and others have used PLGA microparticles to deliver the drug via the pulmonary, nasal and oral routes [2,[17][18][19][20]. However, because of its hydrophilic nature, drug payload was minimal.…”
Section: Introductionmentioning
confidence: 99%
“…These results were caused by the low initial concentration of pentachlorophenol due to its relatively low solubility. The 2,4-dichlorophenol was more bound by the P-PSD than the other two chlorophenols due to its relatively low molecular weight and density, which were considered the reasons for it easy encapsulation, as it would have a greater chance to contact with the P-PSD (Reignier et al 2003;Javot et al 2009). …”
Section: Encapsulation Of Chlorophenols Using P-psdmentioning
confidence: 99%
“…Among different dosage forms, nanoparticles have been identified as a novel class of matrices possessing a great potential as drug carrier [8,9]. Heparin, a highly sulfated glycosamineglycan, is widely used as an injectable anticoagulant, and has the highest charge density of any known biological molecule [10]. It is used clinically to minimize thrombus formation on artificial surfaces.…”
Section: Introductionmentioning
confidence: 99%